Resveratrol suppresses angiogenesis in gliomas: Evaluation by color Doppler ultrasound

Anticancer Research

Volumn 26, Issue 2 A, 2006, Pages 1237-1245

  Chen, Jin Cherng ^a   Chen, Yun ^b   Lin, Jyh Herng ^c   Wu, Jiann Ming ^b   Tseng, Sheng Hong ^c  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Angiogenesis; Color Doppler ultrasound; Glioma; Resveratrol

Indexed keywords

RESVERATROL;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL DENSITY; COLOR ULTRASOUND FLOWMETRY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG EFFECT; GLIOMA; GLIOMA CELL; GROWTH RATE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL RATE; TUMOR BLOOD FLOW; TUMOR GROWTH; TUMOR VOLUME; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; BRAIN NEOPLASMS; CELL GROWTH PROCESSES; GLIOMA; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, INBRED F344; STILBENES; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 33645802631     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Soleas GJ, Diamandis EP and Goldberg DM: Resveratrol: a molecule whose time has come and gone? Clin Biochem 30: 91-113, 1997.
2. Belguendouz L, Fremont L and Linard A: Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem Pharmacol 55: 1347-1355, 1997.
3. Arichi H, Kimura Y, Pkuda H, Baba K, Kozawa M and Arichi S: Effects of stilbene components of the roots of polygonium on lipid metabolism. Chem Pharm Bull 30: 1766-1770, 1982.
4. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S and Takada Y: Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24: 2783-2840, 2004.
5. Cai YJ, Wei QY, Fang JG, Yang L, Liu ZL, Wyche JH and Han Z: The 3,4-dihydroxyl groups are important for trans-resveratrol analogs to exhibit enhanced antioxidant and apoptotic activities. Anticancer Res 24: 999-1002, 2004.
6. Chen Y, Tseng SH, Lai HS and Chen WJ: Resveratrol- induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and exerted antitumor effects on neuroblastoma in mice. Surgery 136: 57-66, 2004.
7. Clement MV, Hirpara JL, Chawdhury SH, Hirpara JL, Chawdhury SH and Pervaiz S: Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92: 996-1002, 1998.
8. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghom AD, Mehta RG, Moon RC and Pezzuto JM: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220, 1997.
9. Kuwajerwala N, Cifuentes E, Gautam S, Menon M, Barrack ER and Reddy GPV: Resveratrol induces prostate cancer cell line entry into S phase and inhibits DNA synthesis. Cancer Res 62: 2488-2492, 2002.
10. Liontas A and Yeger H: Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res 24: 987-998, 2004.
11. Lu R and Serrero G: Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J Cell Physiol 179: 297-304, 1999.
12. Schneider Y, Vincent F, Duranton B, Badolo L, Gosse F, Bergmann C, Seiler N and Raul F: Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett 158: 85-91, 2000.
13. Surh YJ, Hurh YJ, Kang JY, Lee E, Kong G and Lee SJ: Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett 140: 1-10, 1999.
14. Uenobe F, Nakamura S and Miyazawa M: Antimutagenic effect of resveratrol against Trp-P1. Mutat Res 373: 197-200, 1997.
15. Brakenhielm E, Cao R and Cao Y: Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J 15: 1798-1800, 2001.
16. Hsieh TC and Wu JM: Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp Cell Res 249: 109-115, 1999.
17. Igura K, Ohta T, Kuroda Y and Kaji K: Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett 171: 11-16, 2001.
18. Kimura Y and Okuda H: Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 131: 1844-1849, 2001.
19. Tseng SH, Lin SM, Chen JC, Su YH, Huang HY, Chen CK, Lin PY and Chen Y: Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res 10: 2190-2202, 2004.
20. Bosari S, Lee AK, Wiley BD, Heatley GJ, Hamilton MW and Silverman ML: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23: 755-761, 1992.
21. Fleischer AC, Wojcicki WE, Donnelly EF, Pickens DR, Thirsk G, Thurman GB and Hellerqvist CG: Quantified color Doppler sonography of tumor vascularity in an animal model. J Ultrasound Med 18: 547-551, 1999.
22. Weidner N, Folkman J, Pozza F, Bevilaoqua P, Allred EN, Moore DH, Meli S and Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast cancer. J Natl Cancer Inst 84: 1875-1887, 1992.
23. Asselin-Paturel C, Lassau N, Guinebretiere JM, Zhang J, Gay F, Bex F, Hallez S, Leclere J, Peronneau P, Mami-Chouaib F and Chouaib S: Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography. Gene Ther 5: 606-615, 1999.
24. Adler RS, Bell DS, Bamber JC, Moskovic E and Thomas JM: Evaluation of soft-tissue masses using segmented color Doppler velocity images: preliminary observations. Am J Roentgenol 172: 781-788, 1999.
25. Chen CN, Cheng YM, Liang JT, Lee PH, Hsieh FJ, Yuan RH, Wang SM, Chang MF and Chang KJ: Color Doppler vascularity index can predict distant metastasis and survival in colon cancer patients. Cancer Res 60: 2892-2897, 2000.
26. Emoto M, Iwasaki H, Mimura K, Kawarabayashi T and Kikuchi M: Differences in the angiogenesis of benign and malignant ovarian tumors, demonstrated by analyses of color Doppler ultrasound, immunohistochemistry, and microvessel density. Cancer 80: 899-907, 1997.
27. Hata K, Fujiwaki R, Maede Y, Nakayama K, Fukumoto M and Miyazaki K: Expression of thymidine phosphorylase in epithelial ovarian cancer: correlation with angiogenesis, apoptosis, and ultrasound-derived peak systolic velocity. Gynecol Oncol 77: 26-34, 2000.
28. Lee CN, Cheng WF, Chen CA, Chu JS, Hsieh CY and Hsieh FJ: Angiogenesis of endometrial carcinomas assessed by measurement of intratumoral blood flow, microvessel density, and vascular endothelial growth factor levels. Obstet Gynecol 96: 615-621, 2000.
29. Ogura O, Takebayashi Y, Sameshima T, Maeda S, Yamada K, Hata K, Akiba S and Aikou T: Preoperative assessment of vascularity by color Doppler ultrasonography in human rectal carcinoma. Dis Colon Rectum 44: 538-548, 2001.
30. Wu YC, Yuan CC, Hung JH, Chao KC, Yen MS and Ng HT: Power Doppler angiographic appearance and blood flow velocity waveforms in invasive cervical carcinoma. Gynecol Oncol 79: 181-186, 2000.
31. Donnelly EF, Geng L, Wojcicki WE, Fleischer AC and Hallahan DE: Quantified power Doppler US of tumor blood flow correlates with microscopic quantification of tumor blood vessels. Radiology 219: 166-170, 2001.
32. Lassau N, Koscielny S, Opolon P, de Baere T, Peronneau P, Leclere J and Roche A: Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo. Invest Radiol 36: 50-55, 2001.
33. Copeland DD, Talley FA and Bigner DD: The fine structure of intracranial neoplasms induced by the inoculation of avian sarcoma virus in neonatal and adult rats. Am J Pathol 83: 149-176, 1976.
34. Chen CN, Cheng YM, Lin MT, Hsieh FJ, Lee PH and Chang KJ: Association of color Doppler vascularity index and microvessel density with survival in patients with gastric cancer. Ann Surg 235: 512-518, 2002.
35. Taylor KJW, Ramos I, Carter D, Morse SS, Snower D and Fortune K: Correlation of Doppler US tumor signals with neovascular morphologic features. Radiology 166: 57-62, 1998.
36. Folkman J: Clinical applications of research on angiogenesis. N Engl J Med 333: 1757, 1995.
37. Delorme S, Haberkorn U, Kinscherf R, Zuna I, Bahner ML and van Kaick G: Changes of tumor vascularity during gene therapy monitored with color Doppler US. Ultrasound Med Biol 27: 1595-1603, 2001.
38. Baumgartner RW: Transcranial color duplex sonography in cerebrovascular diseases: a systemic review. Cerebrovascular Dis 16: 4-13, 2003.